Live Long Walk Strong rehabilitation program for Mobility Limitation

Phase-Based Estimates
1
Effectiveness
1
Safety
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston, MA
Mobility Limitation
Live Long Walk Strong rehabilitation program - Other
Eligibility
18+
All Sexes
Eligible conditions
Mobility Limitation

Study Summary

This study is evaluating whether a rehabilitation program can help improve gait speed for older veterans.

See full description

Treatment Effectiveness

Study Objectives

This trial is evaluating whether Live Long Walk Strong rehabilitation program will improve 1 primary outcome in patients with Mobility Limitation. Measurement will happen over the course of within 2 weeks, 8 weeks, 16 weeks.

Week 16
Gait Speed

Trial Safety

Trial Design

2 Treatment Groups

8 week wait list control
Live Long Walk Strong

This trial requires 198 total participants across 2 different treatment groups

This trial involves 2 different treatments. Live Long Walk Strong Rehabilitation Program is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Live Long Walk Strong
Other
8 week rehabilitation program
8 week wait list control
Other
8 week wait list then followed by 8 weeks of the Live Long Walk Strong rehabilitation program

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: within 2 weeks, 8 weeks, 16 weeks
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly within 2 weeks, 8 weeks, 16 weeks for reporting.

Closest Location

VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston, MA

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 5 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Veteran
Aged 50 and older
Community dwelling
Ability to speak and understand English
Usual gait speed 0.5 m/s- 1.0 m/s Activity modifications and access to telehealth rehabilitation

Patient Q&A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are common treatments for mobility limitation?

Add answer

The most common treatments for mobility limitation are physical therapy, orthotics and assistive devices, and surgical procedures. Typically, these treatments are focused on reducing pain and disability resulting from mobility limitation. Additional therapies may also be needed for more severe mobility limitations.\n

Unverified Answer

Can mobility limitation be cured?

Add answer

A variety of conditions can result in mobility limitation and there is no single condition that can be deemed the cause. With effective rehabilitation the potential for cure is large.

Unverified Answer

What causes mobility limitation?

Add answer

There are several physical diseases that can contribute to mobility limitation, including heart disease, low back pain, arthritis, spinal disc herniation, and arthritis. If it is not possible to attribute symptoms solely to any single disease, then many patients can be classified as having unexplained mobility limitation for their age.

Unverified Answer

What are the signs of mobility limitation?

Add answer

This area warrants further study. There may be physical signs which indicate mobility limitation, which is related to quality of life. The best predictor of mobility limitation is physical fatigue. A physical examination may be one way that this is assessed.

Unverified Answer

How many people get mobility limitation a year in the United States?

Add answer

The lifetime prevalence of mobility limitation of 47.6% in a community sample of elderly is a conservative estimate that may be significantly higher in individuals who have been diagnosed or treated for depressive symptoms. For example, a substantial proportion of individuals identified as having 'depressive symptoms' by their general practitioner or primary care physician may not have had a formal diagnosis of a depressive disorder (including MDD), as only a minority of such individuals will receive antidepressant treatment. The prevalence of mobility limitation may be even higher in individuals who are receiving treatment for depression due to the inclusion criteria used in clinical practice guidelines for identifying depressive disorder.

Unverified Answer

Have there been any new discoveries for treating mobility limitation?

Add answer

Most RCT for a treatment for mobility limitation are sponsored by a single manufacturer or commercial enterprise, which is a potential source of bias. If a clinical trial is found to be biased, its results will be invalid and can result in unproven treatments being recommended.

Unverified Answer

Does live long walk strong rehabilitation program improve quality of life for those with mobility limitation?

Add answer

For people with mobility difficulty, a daily exercise program of LLW and other daily tasks reduced mobility problems, improving quality of life. The program resulted in higher rate of participation and improved compliance even for elderly subjects.

Unverified Answer

What is live long walk strong rehabilitation program?

Add answer

The live long walk test used in this pilot study provides valuable objective evidence of long bone strength and can be an objective test for guiding patients towards early referral for more aggressive and appropriate care.

Unverified Answer

What is the primary cause of mobility limitation?

Add answer

[The primary cause of mobility limitation is not due to structural abnormalities, but to decreased functional capacity of the patient, which in turn is caused by low physical activity and sedentariness. As many other problems are responsible for low physical activity and sedentariness, these factors should be tackled at the same time as the mobility limitation problem.

Unverified Answer

Have there been other clinical trials involving live long walk strong rehabilitation program?

Add answer

There have been no trials comparing the outcomes of live long walk strong rehabilitation versus standard care or placebo control in clinical settings. The findings of this study need to be carefully viewed in light of the fact that there were patients with less disability at baseline in the live long walk group and they were more compliant than placebo patients. Recent findings underscore the need for large scale clinical trials to investigate the effects of live long walk strong rehabilitation in the context of clinical management of individuals with a disabling condition.

Unverified Answer

Who should consider clinical trials for mobility limitation?

Add answer

Clinicians should know that mobility limitation will be present in their patients as a sign of severe disease unless detected early, and participation in clinical trials of new drugs and therapies in patients with a mobility limitation is not excluded.

Unverified Answer
See if you qualify for this trial
Get access to this novel treatment for Mobility Limitation by sharing your contact details with the study coordinator.